|
OGFOD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.691800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.532100E-02 |
| Normal-vs-Stage2 |
1.923400E-01 |
| Normal-vs-Stage3 |
6.796000E-01 |
| Normal-vs-Stage4 |
6.441600E-01 |
| Stage1-vs-Stage2 |
7.156600E-01 |
| Stage1-vs-Stage3 |
1.014480E-02 |
| Stage1-vs-Stage4 |
3.503400E-01 |
| Stage2-vs-Stage3 |
1.664800E-01 |
| Stage2-vs-Stage4 |
5.821800E-01 |
| Stage3-vs-Stage4 |
5.327200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.849600E-02 |
| Normal-vs-AfricanAmerican |
1.741740E-02 |
| Normal-vs-Asian |
5.402200E-01 |
| Caucasian-vs-AfricanAmerican |
2.967600E-01 |
| Caucasian-vs-Asian |
1.830770E-01 |
| AfricanAmerican-vs-Asian |
6.908100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.157100E-03 |
| Normal-vs-Female |
8.726400E-01 |
| Male-vs-Female |
1.121270E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.160260E-02 |
| Normal-vs-Extreme_Weight |
5.944700E-03 |
| Normal-vs-Obese |
4.662600E-01 |
| Normal-vs-Extreme_Obese |
2.869600E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.693000E-01 |
| Normal_Weight-vs-Obese |
7.448000E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.347800E-01 |
| Extreme_Weight-vs-Obese |
7.526100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.797000E-01 |
| Obese-vs-Extreme_Obese |
1.695240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.873800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.422030E-01 |
| Normal-vs-Age(61-80Yrs) |
2.853900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.300410E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.402790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.247580E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.109900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.236600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.154380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.181000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.761700E-03 |
| Normal-VS-Type2 PRCC |
1.070580E-01 |
| Normal-VS-KIRP CIMP |
5.987600E-04 |
| Normal-VS-Unclassified PRCC |
9.802200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.745200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.95769997382678E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
6.903000E-03 |
| Type2 PRCC-VS-KIRP CIMP |
4.18489999998162E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
1.285400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.224600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.203980E-02 |
| Normal-vs-N1 |
2.780800E-01 |
| Normal-vs-N2 |
3.704000E-01 |
| N0-vs-N1 |
1.777900E-03 |
| N0-vs-N2 |
7.914800E-01 |
| N1-vs-N2 |
2.615600E-01 |
|
|
